Twin Lakes Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$299K Hold
325
0.14% 74
2025
Q4
$349K Hold
325
0.16% 72
2025
Q3
$248K Hold
325
0.11% 77
2025
Q2
$253K Hold
325
0.15% 78
2025
Q1
$268K Hold
325
0.18% 71
2024
Q4
$251K Hold
325
0.16% 75
2024
Q3
$288K Hold
325
0.19% 70
2024
Q2
$294K Hold
325
0.2% 66
2024
Q1
$253K Hold
325
0.17% 75
2023
Q4
$189K Hold
325
0.13% 83
2023
Q3
$175K Hold
325
0.13% 84
2023
Q2
$152K Hold
325
0.11% 93
2023
Q1
$112K Hold
325
0.08% 100
2022
Q4
$119K Hold
325
0.09% 99
2022
Q3
$105K Hold
325
0.08% 104
2022
Q2
$105K Hold
325
0.08% 87
2022
Q1
$93K Hold
325
0.05% 118
2021
Q4
$90K Hold
325
0.05% 125
2021
Q3
$75K Buy
+325
New +$80.2K 0.04% 128

Other funds holding LLY

Twin Lakes Capital Management's LLY Position: Q1 2026 in Review

Twin Lakes Capital Management held its Eli Lilly (LLY) position steady in Q1 2026 at 325 shares worth $299K. The position accounts for 0.14% of the portfolio, ranked #74.

Twin Lakes Capital Management first reported a position in LLY in Q3 2021 and has held it in 19 quarters since. The position peaked at $349K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Twin Lakes Capital Management held 325 shares of Eli Lilly worth $299K as of Q1 2026.
  • Twin Lakes Capital Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.14% of Twin Lakes Capital Management's portfolio in Q1 2026, its #74 holding.
  • Twin Lakes Capital Management first reported a position in Eli Lilly in Q3 2021 and has held it in 19 quarters since.
  • Twin Lakes Capital Management's Eli Lilly position peaked at $349K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Twin Lakes Capital Management's 13F filing for Q1 2026, filed 18 May 2026.